Cell https://doi.org/10.1016/j.cell.2020.11.029 (2020)
Since the recent onset of the COVID-19 pandemic, there have been some reports of suspected cases of reinfection by SARS-CoV-2. The question remains, however, of whether SARS-CoV-2 viral infection can elicit durable immunologic memory responses or whether memory generation is somehow impeded by viral virulence mechanisms. In Cell, Rodda et al. report a longitudinal analysis of adaptive immune memory that had arisen in patients who had experienced mild COVID-19 disease and had recovered. Blood samples taken at 1 and 3 months post-symptom onset contain circulating antibodies specific for the receptor-binding domain (RBD) of the SARS-CoV-2 spike (S) protein, which are capable of inhibiting the interaction with the host ACE2 viral receptor, suggesting that long-lived plasma cells had been generated. RBD-specific memory B cells, identified by tetramer enrichment, are present in convalescent blood and increased in frequency at the later time point. Monoclonal antibodies generated from a subset of these memory B cells are capable of blocking the RBD–ACE2 interaction and neutralizing the virus. Likewise, at 3 months post-infection, patients who have recovered harbor S-specific memory CD8+ and CD4+ T cells, including circulating CXCR5+ follicular helper T cells and CXCR3+ central memory T cells, that respond to restimulation by proliferating and producing cytokines. Thus, durable adaptive memory can arise in response to community-acquired SARS-CoV-2 infection and can potentially provide protection to secondary exposure.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dempsey, L.A. Durable memories. Nat Immunol 22, 7 (2021). https://doi.org/10.1038/s41590-020-00853-6
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-020-00853-6